Received Jun 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | MG5S9 | IM / LA |
her whole arm (left) was swollen.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of swelling arm in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number MG5S9) for prophylaxis. On 18-APR-2025, the patient received the 1st dose of Shingrix (intramuscular use, left arm) .5 ml. On 21-APR-2025, 3 days after receiving Shingrix, the patient experienced swelling arm (Verbatim: her whole arm (left) was swollen.). The outcome of the swelling arm was unknown. It was unknown if the reporter considered the swelling arm to be related to Shingrix. It was unknown if the company considered the swelling arm to be related to Shingrix. Additional Information: GSK Receipt Date: 06-JUN-2025 The pharmacist reported that a patient was vaccinated with her first dose of Shingrix on 18-APR-2025. Consumer informed to the health care professional that 72 hours later she had bad side effects and her whole arm (left) was swollen. No further information was obtained/provided.